Insulin promoter factor, and uses related thereto

Details Insulin promoter factor, and uses related thereto Insulin promoter factor, and uses related thereto

2005-06-21

2005-06-21

Horlick, Kenneth R. (Department: 1637)

Organic compounds -- part of the class 532-570 series

Organic compounds

Carbohydrates or derivatives

C530S350000, C435S006120, C435S007100, C435S091500, C536S024300, C536S024330

Reexamination Certificate

active

06908990

ABSTRACT:
The present invention relates to the discovery in eukaryotic cells, particularly mammalian cells, of novel a transcriptional regulatory factor, referred to hereinafter as “Insulin Promoter Factor 1” or “Ipf1”.

REFERENCES:
patent: 5858973 (1999-01-01), Habener et al.
patent: 6197945 (2001-03-01), Edlund
Barton, “Protein sequence alignment and database scanning”, Protein Structure Prediction: A Practical Approach, IRL Press, New York: 31-63 (1996).
Brinster, R.L. et al., “Factors affecting the efficiency of introducing foreign DNA into mice microinjecting eggs”, PNAS U 82: 4438-4442 (1985).
George et al., Current Methods in Sequence Comparison and Analysis, Marcromolecular Sequencing and Synthesis: Selected Methods and Applications, Alan R. Liss, Inc., New York: 127-149 (1988).
Hammer, R. E. et al., “Production of transgenic rabbits, sheep, and pigs by microinjection”, Nature 315: 680-683 (1985).
Ishaguro, S. et al., “Characterization of a cDNA encoding a novel DNA-binding protein, SPF1, that recognizes SP8 sequences in the 5' upstream regions of genes coding for sporamin and β-amylase from sweet potato”, Mol. Gen. Genet. 244: 563-571 (1994).
Jaenisch, R., “Transgenic Animals”, Science 240: 1468-1474 (1988).
Langer, R. et al., “Tissue Engineering”, Science 260: 920-926 (1993).
McGinnis, W. et al., “Homeobox Genes and Axial Patterning”, Cell 68: 283-302 (1992).
Ohlsson, H. et al., “Novel Insulin Promoter-and Enhancer-Binding Proteins That Discriminate Btween Pancreatic α-and β-Cells”, Mol. Endocrinol. 5 (7): 897-904 (1991).
Ohlsson et al., “IPF1, a homeodomain-containing transactivator of the insulin gene”, EMBO J. 12 (11): 4251-4259 (1993).
Sakoyama, Y. et al., “Cloning of Rat Homeobox Genes”, Biochem. Genet. 32 (9/10): 351-360 (1994).
Serrano M. et al., “A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4”, Nature 366: 704-707 (1993).
Tomlinson, C. et al., “Ectoderm nuclei from sea urchin embroys contain a Spec-DNA binding protein similar to the vertebrate transcription factor USF”, Development 110: 259-272 (1990).
Walker, M.D. et al., “Cell-Specific Expression Controlled by the 5' Flanking Region of Insulin and Chymotrypsin Genes”, Nature 306: 557-561 (1983).
Wall, R.J. et al., “Development of Porcine Ova That Were Centrifuged to Permit Visualization of Pronuclei and Nuclei”, Biol. of Reprod. 32: 645-651 (1985).
Watson, J.D. et al., Molecular Biology of the Gene, 4thed., 1: 313 (1987).
Webster's Ninth New Collegiate Dictionary: 366 (1990).

Affiliated with

Also associated with

Rating

Insulin promoter factor, and uses related thereto does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Insulin promoter factor, and uses related thereto, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Insulin promoter factor, and uses related thereto will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3493195